Victoria five – C
Vancouver – C
Edmonton -6 – C
Regina -5 – C
Winnipeg -1 ° C
Toronto nine – C
Ottawa 7 – C
Montreal – C
Quebec – C
Fredericton 10 – C
Halifax – C
Charlottetown – C
St. John’s C
White Horse -10oC
Yellowknife -5 ‘C
Iqaluit -1 ‘C
Federal regulators approved another quick COVID-19 verification for use in Canada and Ottawa signed a contract for more than 20 million new technology antigen verification kits, officials said Monday.
The immediate Panbio COVID-19 Ag device, which works by detecting express proteins related to coronavirus, can produce effects in less than 20 minutes.
Control was developed through Abbott Laboratories, founded in the United States and is the first immediate control of legal antigens through Health Canada.
Dr. Howard Njoo, Deputy Director of Public Health Canada, said antigen testing is affordable and easy to administer and can be implemented in workplaces where there are close contacts between many other people, such as meatpacking plants, or in the long-term. care centers, homeless shelters, and remote or remote communities.
“Cases are on the rise and testing and tracking are more than ever,” Public Service and Supply Minister Anita Anand said Monday.
Federal Health Minister Patty Hajdu said these antigen tests would play an important role in preventing outbreaks of primary outbreaks, when the effects are temporarily needed to prevent further spread of the virus.
However, antigen testing is designed to replace the characteristics of late-used laboratory tests across the country, Anand said.
“To be clear, the strategy for our acquisitions is not to update the standardized test model, but the ability of provinces and territories to meet the call in test development,” Anand said. Our strategy is a diversification strategy among other types and models of testing “
Anand said 8. 5 million tests will be distributed across Canada until the end of the year. Canada has received features for 12 million additional tests that can be requested in the long run if the government is satisfied with Panbio’s performance.
The federal government has also signed another contract with Abbott Rapid Diagnostics to acquire up to 7. 9 million of its immediate ID NOW molecular tests that are being used through White House officials to monitor the workers’ bodies since April.
Conservative health critic Michelle Rempel Garner said the liberal government failed to catch Canadians through quick trials.
“The check you’re talking about today won’t be in the hands of Canadians until the end of the year. They had months to do it and they failed,” he said. Question period. “The prime minister has not provided quick checks. They probably won’t be here soon. “
With CBC News files
Category
All rights reserved – Radio Canada International 2018